Elastomer Infusion Pump Market Overview: 2026
The global elastomer infusion pump market size was valued at $534 million in 2018, and is estimated to reach at $745 million by 2026, registering a CAGR of 4.2% from 2019 to 2026.
Elastomer infusion pumps are used to administer drugs in a controlled manner into the patient’s body. It is also known as non-electronic medication pumps or balloon pumps. It has advantage in terms of portability, easy to handle, mobility, and also provides high level of control & precision in drug delivery; thus, avoiding error in medication dosage. Drugs such as analgesics, chemotherapy antibiotics, and others, are administered using elastomer infusion pumps. Thus, it has application for pain management, infection management, chemotherapy, and others.
Increase in number of orthopedic procedures and surgery, rise in demand for small disposable ambulatory elastomer infusion pumps, technological developments of novel elastomeric infusion pumps, and surge in prevalence of chronic diseases are the major factors that drive the growth of the global elastomer infusion pump market. In addition, surge in preference for long-term home healthcare, rise in burden on hospitals to reduce healthcare costs, rise in availability of elastomer infusion pumps, increase in adoption of elastomer infusion pumps in ambulatory chemotherapy and analgesic infusion centers are the other factors that contribute toward the growth of the market. Moreover, rise in number of hospitals and ambulatory care centers, and increase in patient preference for effective & affordable surgical treatment are the other factors that contribute toward the growth of the market. However, low income and lack of proper medical attention in the developing countries restrain of elastomer infusion pump market growth.
By Product
Continuous rate pumps is projected as one of the most lucrative segment.
ELASTOMER INFUSION PUMP MARKET SEGMENTATION
The global elastomer infusion pump market is segmented into product, application, end user, and region. By product, the market is categorized into continuous rate pumps, and variable rate pumps. The applications covered in the study include pain management, infection management, chemotherapy, and others. Based on end user, the market is classified into hospitals and clinics, ambulatory care, and home care. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa and rest of LAMEA).
By Application
Pain management holds a dominant position in 2018 and would continue to maintain the lead over the forecast period.
Segment review
By product, the market is divided into continuous rate pumps, and variable rate pumps. At present, the continuous rate pumps segment dominates the global market, and is anticipated to continue this trend over the forecast period. The key factors that drive the market growth are rise in demand for continuous rate elastomeric pumps, wide usage of continuous rate pumps in chronic disease treatment, increase in adoption of elastomer infusion pump for post-operative pain management, and surge in application in cancer treatment.
By Region
Asia-Pacific region would exhibit the highest CAGR of 5.9% during 2019-2026.
Depending on application, the global elastomer infusion pump market is segregated into pain management, infection management, chemotherapy, and others. The pain management segment is the major shareholder in the global elastomer infusion pump market, owing to rise in number of orthopedic procedures & surgeries, increase in use of elastomer infusion pumps for administration of analgesic drugs, and less complications are observed as compared to opioids dosage.
Snapshot of Asia-Pacific elastomer infusion pump market
Asia-Pacific presents lucrative opportunities for the key players operating in the elastomer infusion pump market, due to increase in patient awareness toward benefits offered by elastomer infusion pumps, rise in number of hospitals equipped with advanced medical facilities, development of the R&D sector, rise in healthcare reforms, and technological advancements in elastomer infusion pump products. Moreover, rise in demand for elastomer infusion pump, and presence of high population base incomes contribute toward the growth of the market. Moreover, surge in focus of leading manufacturers on expanding their geographic presence in emerging Asia-Pacific countries to capture high elastomer infusion pump market share is expected to drive the growth of the market in the region.
The key players profiled in this report include B Braun Melsungen Ag, Baxter International Inc., Halyard Health, Heka Healthcare, Nipro Medical Corporation (Nipro Medical Europe NV), Palex Medical SA, Pfizer Inc. (Hospira Inc.), Pfm Medical Ag, and PROMECON GmbH.
Key Benefits for Stakeholders
- The study provides an in-depth analysis of the elastomer infusion pump market size along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers elastomer infusion pump market analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
- A comprehensive analysis of four regions is provided to determine the prevailing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook and global elastomer infusion pump market growth.
Elastomer Infusion Pump Market Report Highlights
| Aspects | Details |
 By Product |
|
 By Application |
|
 By End User |
|
 By Region |
|
 Key Market Players | Samtronic SA, Halyard Health, Pfizer Inc. (Hospira Inc.), B Braun Melsungen Ag, Nipro Medical Corporation (Nipro Medical Europe NV), Baxter International Inc., Palex Medical SA, Heka Healthcare, PROMECON GmbH, Pfm Medical Ag |
Analyst Review
The elastomer infusion pumps are non-electric, disposable medical devices that deliver intravenous fluids such as antibiotics, analgesics, chemotherapy, and other drugs in a controlled amount into a patient’s body. The essential pressure required for administration of the drug is derived from the elastomer layer existing inside the pump. The elastomer infusion pumps are used in intravenous drug delivery in hospitals and clinics, ambulatory care, and home care.
Rise in demand for elastomer infusion pumps, increase in preference of long-term home healthcare, technological development of novel elastomeric infusion pumps, rise in number of patients undergoing orthopedic surgeries, and increase in prevalence of chronic diseases significantly boost the growth of the elastomer infusion pump market. Moreover, rise in burden on hospitals to reduce treatment costs, rise in patient awareness toward elastomer infusion pumps, and government funding & initiatives for the R&D of elastomer infusion pumps, further drive the market growth. However, low income and lack of proper medical attention in the developing countries are expected to restrain the growth of the market.
North America is expected to remain dominant during the forecast period, due to development of technologically advanced elastomer infusion pumps, rise in number of hospitals and ambulatory care centers. Conversely, Asia-Pacific is expected to offer lucrative opportunities to the key players during the forecast period, due to development in the R&D and healthcare sectors along with rise in demand for elastomer infusion pumps.
The market value of global elastomer infusion pump market was $533.8 million in 2018.
The forecast period is from 2019 to 2026.
The market value of global elastomer infusion pump market in 2019 is $557.0 million.
The adoption of elastomer infusion pump is expected to rise in demand for small disposable elastomer infusion pump, due to its long term home care rehabilitation program, surge in prevalence of chronic diseases, growth in availability of elastomer infusion pumps, technological development of novel elastomeric infusion pumps majorly driving the market growth
The base year calculated in the report is 2018.
Yes, Baxter International Inc. is profiled in the report.
Emerging countries of Asia-Pacific region are growing at a growth% of 5.9%. Japan, China, Australia, India, South Korea are expected grow at a CAGR of 5.8%, 6.9%, 5.0%, 6.6%, 5.4% respectively.
The North America market held a major share in the elastomer infusion pump market in 2018 and is expected to continue the trend in the forecasting period. This is attributed to development of technologically advanced elastomer infusion pump products, increased adoption of elastomer infusion pump products, and rise in non-government & government initiatives to promote healthcare are driving the elastomer infusion pump market in North America
Loading Table Of Content...
